Table 3 The compliance before, 6, 12, and 24 months after the implementation of clinical guidelines for suicidal behaviour in % (n).
From: Supported local implementation of clinical guidelines in psychiatry: a two-year follow-up
Implementation clinics | Control clinics | |||
|---|---|---|---|---|
Indicator | % (n) | OR (95% CI) | % (n) | OR (95% CI) |
Accessibility/wait time | ||||
0 months | 15.7 (19) | reference | 29.5 (18) | reference |
6 months | 14.2 (17) | 0.9 (0.4-1.8) | 31.7 (19) | 1.1 (0.5-2.4) |
12 months | 70.4 (169) | 13.7 (7.7-24.4) | 0 | na |
24 months | 59.2 (142) | 8.3 (4.7-14.6) | 0 | na |
Diagnostic assessment | ||||
0 months | 49.6 (60) | reference | 26.2 (16) | reference |
6 months | 73.3 (88) | 2.9 (1.7-5.0) | 16.7 (10) | 0.6 (0.2-1.5) |
12 months | 83.3 (200) | 5.4 (3.2-8.9) | 0.8 (1) | 0 (0.0-0.2) |
24 months | 91.7 (220) | 11.8 (6.5-21.2) | 0 | na |
Diagnostic instrument | ||||
0 months | 0 | reference | 0 | reference |
6 months | 7.5 (9) | na | 0 | na |
12 months | 0 | na | 0 | na |
24 months | 7.5 (18) | na | 0 | na |
Standardized rating scale | ||||
0 months | 41.3 (50) | reference | 27.9 (17) | reference |
6 months | 67.5 (81) | 3.0 (1.7-5.0) | 16.7 (10) | 0.5 (0.2-1.4) |
12 months | 79.2 (190) | 5.5 (3.4-8.9) | 0 | na |
24 months | 78.3 (188) | 5.2 (3.2-8.4) | 0.8 (1) | 0.0 (0.0-0.2) |
Standardized rating scale during treatment | ||||
0 months | 16.5 (20) | reference | 16.4 (10) | reference |
6 months | 52.5 (63) | 5.8 (3.2-10.5) | 10.0 (6) | 0.6 (0.2-1.7) |
12 months | 22.9 (55) | 1.6 (0.9-2.7) | 0.8 (1) | 0.04 (0.02-0.35) |
24 months | 55.8 (134) | 6.6 (3.8-11.3) | 5.0 (6) | 0.3 (0.1-0.9) |
Substance/drug abuse | ||||
0 months | 52.1 (63) | reference | 55.7 (34) | reference |
6 months | 64.2 (77) | 1.7 (1.0-2.9) | 56.7 (34) | 1.0 (0.5-2.1) |
12 months | 77.5 (186) | 3.4 (2.1-5.5) | 25.0 (30) | 0.3 (0.2-0.5) |
24 months | 80.0 (192) | 3.8 (2.4-6.2) | 29.2 (35) | 0.3 (0.1-0.6) |
Treatment (care) plan | ||||
0 months | 37.4 (68) | reference | 44.3 (27) | reference |
6 months | 58.9 (106) | 4.4 (2.5-7.6) | 41.7 (25) | 0.9 (0.4-1.9) |
12 months | 67.1 (161) | 4.4 (2.7-7.1) | 0.8 (1) | 0.0 (0.0-0.1) |
24 months | 79.2 (190) | 8.0 (4.9-13.3) | 0.8 (1) | 0.0 (0.0-0.1) |
Evaluation/outcome | ||||
0 months | 20.7 (25) | Reference | 19.7 (12) | reference |
6 months | 47.5 (57) | 3.5 (2.0-6.2) | 8.3 (5) | 0.4 (0.1-1.2) |
12 months | 25.8 (62) | 1.3 (0.8-2.3) | 0 | na |
24 months | 51.7 (124) | 4.1 (2.5-6.9) | 0 | na |
Continuity | ||||
0 months | 86.0 (104) | reference | 49.2 (30) | reference |
6 months | 81.7 (98) | 0.7 (0.4-1.5) | 31.7 (19) | 0.5 (0.2-1.1) |
12 months | 96.3 (231) | 4.2 (1.8-9.9) | 0 | na |
24 months | 91.3 (219) | 1.7 (0.9-3.5) | 0 | na |
Suicide assessment | ||||
0 months | 55.4 (67) | reference | 82.0 (50) | reference |
6 months | 93.3 (112) | 13.6 (5.9-31.5) | 73.3 (44) | 0.6 (0.2-1.4) |
12 months | 87.1 (209) | 6.1 (3.5-10.6) | 50.0 (60) | 0.2 (0.1-0.5) |
24 months | 97.1 (233) | 33.6 (14.1-80.2) | 56.7 (68) | 0.3 (0.1-0.6) |
Specialist assessment | ||||
0 months | 50.4 (61) | reference | 83.6 (51) | reference |
6 months | 85.4 (103) | 6.5 (3.4-12.3) | 83.3 (50) | 1.0 (0.4-2.6) |
12 months | 87.5 (210) | 7.5 (4.4-12.9) | 86.7 104) | 1.3 (0.5-3.0) |
24 months | 91.7 (220) | 11.8 (6.5-21.5) | 71.7 (86) | 0.5 (0.2-1.1) |
Follow-up | ||||
0 months | 72.7 (88) | reference | 75.4 (46) | reference |
6 months | 88.3 (106) | 2.9 (1.5-5.8) | 65.0 (39) | 0.6 (0.3-1.4) |
12 months | 86.3 (207) | 2.4 (1.4-4.1) | 34.2 (41) | 0.2 (0.1-0.3) |
24 months | 92.1 (221) | 4.5 (2.4-8.3) | 37.5 (45) | 0.2 (0.1-0.4) |
Evaluation assessment | ||||
0 months | 32.2 (39) | reference | 18.0 (11) | reference |
6 months | 64.2 (77) | 4.0 (2.3-6.9) | 13.3 (8) | 0.6 (0.2-1.6) |
12 months | 63.8 (153) | 3.8 (2.4-6.1) | 6.7 (8) | 0.3 (0.1-0.8) |
24 months | 75.0 (180) | 6.8 (4.2-11.2) | 10.8 (13) | 0.4 (0.2-1.1) |